Efficacy of a ketogenic diet in resistant myoclono-astatic epilepsy: A French multicenter retrospective study

Epilepsy Research

Volumn 131, Issue , 2017, Pages 64-69

  Stenger, Elodie ^a   Schaeffer, Mickael ^a   Cances, Claude ^c   Motte, Jacques ^d   Auvin, Stéphane ^e   Ville, Dorothée ^f   Maurey, Hélène ^g   Nabbout, Rima ^b   de Saint Martin, Anne ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d Hôpital Universitaire de Reims   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f Hopital Universitaire   (France)

^g BICÊTRE HOSPITAL   (France)

Author keywords

Doose syndrome; Epileptic encephalopathy; Ketogenic diet; Myoclono astatic epilepsy; Resistant epilepsy

Indexed keywords

ARTICLE; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; FOLLOW UP; HUMAN; KETOGENIC DIET; MALE; MULTICENTER STUDY; MYOCLONIC ASTATIC EPILEPSY; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; CLINICAL TRIAL; DIET THERAPY; DRUG RESISTANT EPILEPSY; ELECTROENCEPHALOGRAPHY; FRANCE; INFANT; MYOCLONUS EPILEPSY; PRESCHOOL CHILD; PROCEDURES; TRENDS;

CHILD, PRESCHOOL; DIET, KETOGENIC; DRUG RESISTANT EPILEPSY; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85014363558     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2017.02.005     Document Type: Article

References (27)

1. Berg, A.T., Berkovic, S.F., Brodie, M.J., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 (2010), 676–685.
2. Bergqvist, A.G.C., Myoclonic astatic epilepsy and the use of the ketogenic diet. Epilepsy Res. 100 (2012), 258–260.
3. Biton, V., Montouris, G.D., Ritter, F., et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology 52 (1999), 1330–1337.
4. Caraballo, R.H., Cersósimo, R.O., Sakr, D., et al. Ketogenic diet in patients with myoclonic-astatic epilepsy. Epileptic. Disord. 8 (2006), 151–155.
5. Caraballo, R.H., Flesler, S., Pasteris, M.C., et al. Myoclonic epilepsy in infancy: an electroclinical study and long-term follow-up of 38 patients. Epilepsia 54 (2013), 1605–1612.
6. Chen, W., Kossoff, E.H., Long-term follow-up of children treated with the modified Atkins diet. J. Child Neurol. 27 (2012), 754–758.
7. Doege, C., May, T.W., Siniatchkin, M., et al. Myoclonic astatic epilepsy (Doose syndrome) a lamotrigine responsive epilepsy. Eur. J. Paediatr. Neurol. 17 (2013), 29–35.
8. Doose, H., Myoclonic-astatic epilepsy. Epilepsy Res.(Suppl. (6)), 1992, 163–168.
9. Dravet, C., Guerrini, R., Bureau, M., Epileptic syndromes with drop seizures in children. Beaumanoir, A., Anderman, F., Avanzini, G., (eds.) Falls in Epileptic and Non Epileptic Seizures During Childhood, 1997, John Libbey, London, 95–111.
10. Dulac, O., Kaminska, A., Use of lamotrigine in Lennox-Gastaut and related epilepsy syndromes. J. Child Neurol. 12:Suppl. 1 (1997), S23–28.
11. Guerrini, R., Parmeggiani, L., Bonnani, P., et al. L’épilepsie myoclono-astatique. Roger, J., Bureau, M., Dravet, C., (eds.) Les syndromes épileptiques de l'enfant et l'adolescent, 2005, John Libbey Eurotext, Montrouge, 103–114.
12. Henderson, C.B., Filloux, F.M., Alder, S.C., et al. Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. J. Child Neurol. 21 (2006), 193–198.
13. Commission on Classification and Terminology of the International League Against Proposal for revised classification of epilepsies and epileptic syndromes, 1989, Epilepsia, 30, 389–399.
14. Kaminska, A., Ickowicz, A., Plouin, P., et al. Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res. 36 (1999), 15–29.
15. Kilaru, S., Bergqvist, A.G., Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia. Epilepsia 48 (2007), 1703–1707.
16. Kossoff, E.H., Dorward, J.L., The modified atkins diet. Epilepsia 49:Suppl. 8 (2008), 37–41.
17. Kossoff, E.H., Bosarge, J.L., Miranda, M.J., et al. Will seizure control improve by switching from the modified Atkins diet to the traditional ketogenic diet?. Epilepsia 51 (2010), 2496–2499.
18. Motte, J., Trevathan, E., Arvidsson, J.F., et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N. Engl. J. Med. 337 (1997), 1807–1812.
19. Mullen, S.A., Marini, C., Suls, A., et al. Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch. Neurol. 68 (2011), 1152–1155.
20. Nangia, S., Caraballo, R.H., Kang, H.C., et al. Is the ketogenic diet effective in specific epilepsy syndromes?. Epilepsy Res. 100 (2012), 252–257.
21. Oguni, H., Fukuyama, Y., Imaizumi, Y., et al. Video-EEG analysis of drop seizures in myoclonic astatic epilepsy of early childhood (Doose syndrome). Epilepsia 33 (1992), 805–813.
22. Oguni, H., Tanaka, T., Hayashi, K., et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics 33 (2002), 122–132.
23. Porta, N., Vallée, L., Boutry, E., et al. Comparison of seizure reduction and serum fatty acid levels after receiving the ketogenic diet and modified Atkins diet. Seizure 18 (2009), 359–364.
24. SFEIM, 2006. Le régime cétogène et son application pratique. Inf. Diet. février.
25. Scheffer, I.E., Berkovic, S.F., Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain J. Neurol. 120 (1997), 479–490.
26. Simard-Tremblay, E., Berry, P., Owens, A., et al. High-fat diets and seizure control in myoclonic-astatic epilepsy: a single center's experience. Seizure 25 (2015), 184–186.
27. Stephani, U., The natural history of myoclonic astatic epilepsy (Doose syndrome) and Lennox-Gastaut syndrome. Epilepsia 47 (2006), 53–55.